Another lncRNA, growth arrest-specific 5 (GAS5), may affect various respiratory diseases, including lung cancer, asthma, and fibrosis [10–12] ; however, there is no study on its mechanisms of action and involvement in CS-caused airway remodeling. Here, GAS5 is linked to asthma.